Addex Therapeutics (ADXN) Current Assets: 2022-2025
Historic Current Assets for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to $3.2 million.
- Addex Therapeutics' Current Assets fell 38.11% to $3.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.2 million, marking a year-over-year decrease of 38.11%. This contributed to the annual value of $4.0 million for FY2024, which is 14.62% down from last year.
- Addex Therapeutics' Current Assets amounted to $3.2 million in Q2 2025, which was down 9.73% from $3.6 million recorded in Q1 2025.
- Addex Therapeutics' Current Assets' 5-year high stood at $18.6 million during Q1 2022, with a 5-year trough of $3.2 million in Q2 2025.
- In the last 3 years, Addex Therapeutics' Current Assets had a median value of $4.7 million in 2023 and averaged $5.3 million.
- Data for Addex Therapeutics' Current Assets shows a maximum YoY plummeted of 59.77% (in 2023) over the last 5 years.
- Quarterly analysis of 4 years shows Addex Therapeutics' Current Assets stood at $8.1 million in 2022, then tumbled by 41.26% to $4.8 million in 2023, then dropped by 15.32% to $4.0 million in 2024, then crashed by 38.11% to $3.2 million in 2025.
- Its Current Assets was $3.2 million in Q2 2025, compared to $3.6 million in Q1 2025 and $4.0 million in Q4 2024.